JPMorgan raised the firm’s price target on Clorox (CLX) to $135 from $133 and keeps a Neutral rating on the shares. The firm reduced estimates after the company last week at a conference highlighted a slower than expected ramp-up in order fulfillment. It cites the stock’s re-rating for the target increase.
Claim 55% Off TipRanks
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Discover top-performing stock ideas and upgrade to a portfolio of market leaders with Smart Investor Picks
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on CLX:
- Clorox Faces Challenges with ERP Implementation and Competitive Pressures, Leading to Hold Rating
- Clorox Faces Operational Challenges and Market Share Concerns Amid ERP Transition, Earning a Hold Rating
- Clorox’s Modest Growth Outlook Amidst Challenges and Strategic Focus
- Clorox Faces Challenges Amid Disappointing Q4 Results and Strategic Uncertainties
- Clorox Earnings Call: Mixed Results Amid Transformation